|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | MYC oncogenes and human neoplastic disease显示文摘 | Nesbit CE Tersak JM Prochownik EV | | 0，，19： | 1 |
| 2 | MYC oncogenes and human neoplastic disease 显示文摘 | Nesbit CE Tersak TM Prochownik EV | 1999 | Oncogene1999，18，19： | 1 |
| 3 | Pag,a putative tumor suppressor,interacts with the Myc Box Ⅱ domain of c-Myc and selectively alters its biological function and target gene expression显示文摘 | Mu ZM Yin XY Prochownik EV | | 0，，45： | 1 |
| 4 | Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc–Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice显示文摘 | Jianxia Guo Robert A. Parise Erin Joseph Merrill J. Egorin John S. Lazo Edward V. Prochownik Julie L. Eiseman | 2009 | Cancer Chemotherapy and Pharmacology2009，，4： | 1 |
| 5 | Pag, a putative tumor suppressor, interacts with the Myc Box Ⅱ domain of c-Myc and selectively alters its biological function and target gene expression 显示文摘 | Mu ZM Yin XY Prochownik EV | 2002 | J Biol Chem2002，277，43： | 1 |
| 6 | Pag, a putative tumor suppressor, interacts with the Myc Box II domain of c-Myc and selectively alters its biological function and target gene expression显示文摘 | Mu Z M Yin X Y Prochownik E V | 2002 | J Biol Chem2002，277，43： | 1 |
| 7 | Myc oncogenes and human neoplastic disease显示文摘 | Nesbit CE Tersak JM Prochownik EV | | 0，，19： | 1 |
| 8 | Myc oncogene and human neoplastic disease 显示文摘 | Nesbit CE Tersak K Prochownik EV | 1999 | Oncogene1999，18，19： | 1 |
| 9 | Commonly occurring loss and mutation of the MXI1 gene in prostate cancer 显示文摘 | Prochownik EV Eagle Grove L Deubler D | 1998 | Genes Chromosomes Cancer1998，22，4： | 1 |
| 10 | e-Myc is required for the CHREBP-de pendent activation of glucose-responsive genes显示文摘 | Zhang P Metukuri M R Bindom S M Prochownik E V O'Do herty R M Scott D K | 2010 | Mol Endo crinol2010，24，： | 1 |
| 11 | C-myc as a therapeutic target in cancer显示文摘 | PROCHOWNIK E V | 2004 | Expert Rev Anticancer Ther2004，4，2： | 1 |
| 12 | c-Myc as a therapeutic target in cancer 显示文摘 | PROCHOWNIKE E V | 2004 | Expert Rev Anticancer Ther2004，4，2： | 1 |
| 13 | MYC oncogenes and human neoplastic disease显示文摘 | Nesbit C E Tersak J M Prochownik E V | 1999 | Oncogene1999，18，： | 1 |
| 14 | MYC oneogenes and human neoplastic disease 显示文摘 | Nesbit CE Tersak JM Prochownik EV | 1999 | Oncogene1999，18，19： | 1 |
| 15 | MYC oncogenes and human neoplastic disease 显示文摘 | NESBIT C E TERSAK J M PROCHOWNIK E V | 1999 | Oncogene1999，18，： | 1 |
| 16 | c-Myc : linking transformation and genomic instability显示文摘 | Prochownik EV | 2008 | Curr Mol Med2008，8，6： | 1 |
| 17 | c-Myc:linking transformation and genomic instability显示文摘 | Prochownik EV | 2008 | Curr Mol Med2008，8，6： | 1 |
| 18 | MYC oncogenes and human neoplastic disease 显示文摘 | Nesbit CE Tersak JM Prochownik EV | 1999 | Oncogene1999，18，19： | 1 |
| 19 | C-myc and bcl-2 modulate P53 function by altering P53 subcellular trafficking during the cell cycle显示文摘 | Ryan J J Prochownik E Gottlieb C A | 1994 | Proc Natl Acad Sci USA1994，91，13： | 1 |
| 20 | Myc oncogenes and human neoplastic disease显示文摘 | Nesbit CE Tersak JM Prochownik EV | 1999 | Oneogene1999，4，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员